Agilent Technologies Inc. (A) Introduces Custom Oligo FISH Solution For Cytogenetic And Pathology Research Labs
7/15/2014 10:49:51 AM
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE:A) today introduced a molecular solution that combines its Oligo Library Synthesis capability for FISH (fluorescence in situ hybridization) with its SureDesign online application to produce custom FISH probes. Used together, these powerful tools enable laboratories to maintain complete control over probe coverage and achieve maximum target-sequence-specificity for both human and animal models.
“Many cytogenetic labs must perform orthogonal testing to verify the results of their research,” said Victor Fung, senior global marketing director for Agilent’s Diagnostics and Genomics business. “Now with this expanded custom FISH solution, they can easily design high-quality assays in significantly less time.”
Help employers find you! Check out all the jobs and post your resume.
comments powered by